CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol. 2016;22(3):350-358.   Published online 2016 September 25    DOI: https://doi.org/10.3350/cmh.2016.0019

Excel Download

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Clinical and Molecular Hepatology. 2016;22(3):350-358   Crossref logo
Link1 Link2 Link3

Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy
Journal of Gastroenterology and Hepatology. 2010;25(8):1374-1380   Crossref logo
Link1

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine
Journal of Viral Hepatitis. 2008;15(12):922-924   Crossref logo
Link1

Entecavir plus adefovir combination therapy versus lamivudine add-on adefovir for lamivudine-resistant chronic hepatitis B: A meta-analysis
The Journal of Clinical Pharmacology. 2014;54(9):959-967   Crossref logo
Link1

69 Comparison of the anti-HBV activities of lamivudine, adefovir, famciclovir, lobucavir, and emtricitabine against wild-type and lamivudine-resistant HBV polymerases in vitro
Antiviral Research. 2000;46(1):A56   Crossref logo
Link1 Link2

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Journal of Medical Virology. 2010;82(11):1835-1842   Crossref logo
Link1 Link2

501 Adefovir dipivoxil alone or in combination with lamivudine in HBeAg negative patients with lamivudine resistant chronic hepatitis B: A prospective, randomized study
Journal of Hepatology. 2005;42:181   Crossref logo
Link1 Link2

504 Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
Journal of Hepatology. 2005;42:182   Crossref logo
Link1 Link2

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir
Journal of Viral Hepatitis. 2011;18(10):e432-e438   Crossref logo
Link1

“De novo” combination with adefovir and lamivudine is more effective than adefovir “add on” and as effective as lamivudine monotherapy in antiviral treatment of chronic HBV infection
Digestive and Liver Disease. 2008;40(5):A18   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.